Corvus Pharmaceuticals Inc.
CRVS | NASDAQ
$12.42
-$0.14 (-1.11%)
At close: Sep 21, 2026, 4:00 PM ET
$12.42
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Institutional Ownership
Net InflowTotal Institutions
173
Total Ownership
77.75%
Capital Flow
+$663.67M
Shares Change
+23.29M
Ownership Distribution
Institutions (77.75%)
Others (22.25%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
67
Increased Positions
125
Reduced Positions
29
Closed Positions
27
New (67)
Increased (125)
Reduced (29)
Closed (27)
Options Sentiment & Activity
bullishPut/Call Ratio
0.332
Call Flow
1,295,570
Put Flow
430,700
Calls (75%)
Puts (25%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Tudor Investment Corp ET AL | 0.02% -20.01% | < 0.01% | 21.99K | 276.22K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 7.96% -12.26% | 2.09% +84.55% | 7.17M 0.00% | 104.82M +90.00% | |
| Blackrock, Inc. | 6.85% +6.90% | < 0.01% +139.29% | 6.16M +21.84% | 90.13M +131.49% | |
| State Street Corp | 3.96% +12.22% | < 0.01% +150.09% | 3.57M +27.89% | 52.17M +143.00% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove CRVS